FDA will drop two-study requirement for new drug approvals, aiming to speed access
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals ...
FDA chief Marty Makary says 'everything should be over-the-counter' unless drug is unsafe or addictive
Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes ...
FDA's Marty Makary: Everything should be over-the-counter unless it's unsafe or requires monitoring
FDA's Marty Makary sits down with CNBC's Annika Kim Constantino to discuss the vaccine regulatory environment, compounding GLP-1 drugs and his efforts to change a large swath of prescription drugs to ...